Aflac (NYSE:AFL) Given New $105.00 Price Target at Truist Financial

Aflac (NYSE:AFL - Get Free Report) had its price target boosted by investment analysts at Truist Financial from $100.00 to $105.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a "hold" rating on the financial services provider's stock. Truist Financial's price target points to a potential upside of 0.64% from the company's previous close.

A number of other research analysts also recently issued reports on AFL. Citigroup lifted their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 23rd. Morgan Stanley increased their price objective on Aflac from $91.00 to $98.00 and gave the company an "equal weight" rating in a report on Monday, August 19th. Evercore ISI boosted their target price on Aflac from $84.00 to $90.00 and gave the stock an "underperform" rating in a research note on Thursday, September 26th. Piper Sandler increased their price target on Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a research note on Wednesday, October 2nd. Finally, TD Cowen assumed coverage on Aflac in a research note on Wednesday, October 9th. They set a "hold" rating and a $102.00 price target on the stock. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $97.87.

Aflac Stock Down 0.4 %

Shares of NYSE:AFL traded down $0.46 during trading hours on Friday, hitting $104.33. The company's stock had a trading volume of 1,716,948 shares, compared to its average volume of 2,232,530. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.10. The firm's fifty day moving average price is $110.58 and its 200 day moving average price is $97.51. Aflac has a 52 week low of $75.07 and a 52 week high of $115.50. The company has a market capitalization of $58.43 billion, a price-to-earnings ratio of 15.93, a P/E/G ratio of 2.24 and a beta of 0.95.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.70 by $0.46. The business had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a return on equity of 16.51% and a net margin of 22.02%. The business's revenue was down 40.4% compared to the same quarter last year. During the same period last year, the business posted $1.84 EPS. As a group, research analysts expect that Aflac will post 6.83 EPS for the current year.

Insider Activity

In related news, Director Thomas J. Kenny sold 2,000 shares of the company's stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the transaction, the director now owns 18,158 shares of the company's stock, valued at approximately $1,796,552.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.90% of the company's stock.

Institutional Trading of Aflac

Institutional investors and hedge funds have recently modified their holdings of the stock. Y.D. More Investments Ltd purchased a new position in Aflac in the 2nd quarter valued at $25,000. Catalyst Capital Advisors LLC purchased a new position in shares of Aflac in the third quarter worth about $51,000. Valued Wealth Advisors LLC boosted its position in Aflac by 116.7% during the third quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider's stock worth $54,000 after acquiring an additional 258 shares during the last quarter. Fairscale Capital LLC purchased a new stake in Aflac during the 2nd quarter valued at about $54,000. Finally, Cedar Wealth Management LLC acquired a new stake in Aflac in the 1st quarter valued at about $50,000. Hedge funds and other institutional investors own 67.44% of the company's stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.